Calculate the Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score. Screens for necrotizing soft tissue infections from routine lab values.
The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score is a screening tool that uses routine laboratory values to distinguish necrotizing soft tissue infections (NSTIs) from other severe soft tissue infections. Developed by Wong et al. in 2004, it combines CRP, WBC, hemoglobin, sodium, creatinine, and glucose into a 13-point score.
Necrotizing fasciitis is a rapidly progressive, life-threatening surgical emergency with mortality rates of 20-40% even with treatment. Delay in surgical debridement is the strongest modifiable risk factor for death — every hour of delay increases mortality. The clinical challenge is that early necrotizing fasciitis can be indistinguishable from severe cellulitis, and the window for intervention is narrow.
The LRINEC score was designed to aid this difficult early differentiation. A score ≥8 has a positive predictive value exceeding 75% for necrotizing fasciitis. However, it has important limitations and should never be used to exclude NF when clinical suspicion is high.
early diagnosis of necrotizing fasciitis can literally save lives and limbs. The LRINEC score provides a systematic way to assess the probability of NSTI using labs that are typically ordered anyway in the workup of severe soft tissue infections.
Critically, the LRINEC score is a "rule-in" tool, not a "rule-out" tool. A low LRINEC score does not exclude NF if clinical features are concerning (pain out of proportion, crepitus, bullae, rapidly expanding erythema, sepsis).
LRINEC Score (0-13 points): CRP ≥150 mg/L: 4 points WBC 15-25 × 10³: 1; <5 or >25: 2 points Hemoglobin 11-13.4: 1; <11: 2 points Sodium <135: 2 points Creatinine >1.6: 2 points Glucose >180: 1 point ≤5: Low risk | 6-7: Intermediate | ≥8: High risk
Result: LRINEC 6 — Intermediate Risk
With CRP 200 mg/L (4 pts), WBC 18 (1 pt), Hb 12 (1 pt), the intermediate score of 6 cannot rule out NF. CT imaging and urgent surgical consultation are recommended. If there is pain out of proportion to exam findings or rapidly progressive erythema, proceed directly to OR exploration.
The "finger test" is a bedside diagnostic procedure: under local anesthesia, a 2cm incision is made through skin and subcutaneous tissue to the deep fascia. Findings diagnostic for NF: lack of bleeding, dishwater-gray tissue, lack of tissue resistance to finger probing along the fascial plane ("positive finger test"), and foul-smelling discharge. This can be performed at bedside in the ED and is faster than CT imaging.
NF management has three pillars: (1) Aggressive surgical debridement — wide excision of all necrotic tissue, with planned return to OR every 24-48 hours for re-exploration until no further necrosis is found. (2) Broad-spectrum IV antibiotics: vancomycin + piperacillin-tazobactam + clindamycin (clindamycin specifically for its anti-toxin effect). (3) ICU-level resuscitation and organ support. Hyperbaric oxygen therapy is adjunctive and should never delay surgery.
Fournier gangrene is necrotizing fasciitis of the perineum/genital region, with mortality rates approaching 20-40%. Risk factors include diabetes, alcoholism, malignancy, and immunosuppression. The Fournier Gangrene Severity Index (FGSI) is a disease-specific scoring system that outperforms LRINEC in this specific population.
Sensitivity varies significantly across studies: 48-90%. The original validation showed high sensitivity at LRINEC ≥6, but subsequent multicenter studies found lower sensitivity (~68-72%). This means 28-32% of NF cases may be missed by LRINEC. A negative LRINEC should NEVER override clinical concern.
Pain out of proportion to examination findings (the most important early sign), rapidly expanding erythema, crepitus on palpation, hemorrhagic bullae, skin necrosis, fever with disproportionate toxicity, wound dishwater-gray drainage, failed improvement on IV antibiotics within 24-48h, and crepitus or gas on imaging. Use this as a practical reminder before finalizing the result.
If clinical suspicion is high (septic shock, crepitus, rapidly progressive), go directly to OR — imaging should never delay surgical exploration in highly suspicious cases. CT with contrast is the best imaging modality (sensitivity ~80-90%) and can show fascial thickening, gas, and fluid tracking. MRI is more sensitive but takes longer.
Type I (polymicrobial, most common): mixed aerobic-anaerobic flora, typically abdominal/perineal. Type II (monomicrobial): Group A Streptococcus or Staphylococcus aureus, often in extremities. Type III: Vibrio vulnificus (saltwater exposure) or Aeromonas (freshwater). Empiric antibiotics should cover all: vancomycin + piperacillin-tazobactam + clindamycin.
In the original LRINEC derivation, CRP ≥150 mg/L was the single strongest discriminator between NF and cellulitis/abscess. CRP reflects the intensity of systemic inflammation, and the massive tissue destruction in NF produces very high CRP levels. However, CRP can be elevated in many conditions and takes 12-24h to rise.
Diabetes is the most common comorbidity in NF patients (30-60%). Diabetic patients may have baseline lab abnormalities (hyperglycemia, renal insufficiency) that increase LRINEC scores even without NF. Conversely, immunocompromised patients may have blunted CRP and WBC responses, falsely lowering the score in true NF.